Cx Institutional Eagle Pharmaceuticals, Inc. Transaction History

Cx Institutional

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 29, 2020	SELL	$34.37 - $60.07 $3,436 - $6,007	-100 Closed	0 $0
Q3 2019 Oct 10, 2019	BUY	$53.25 - $59.98 $5,325 - $5,998	100 New	100 $6,000
Q2 2019 Jul 17, 2019	SELL	$46.61 - $58.45 $4,661 - $5,845	-100 Closed	0 $0
Q2 2018 Jul 12, 2018	BUY	$51.25 - $76.62 $5,125 - $7,662	100 New	100 $8,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Cx Institutional, based on Form 13F filings with the SEC.

Stay updated on Cx Institutional with notifications on news.